ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RENE Reneuron Group Plc

3.05
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.05 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 530k -5.41M -0.0946 -0.32 1.74M
Reneuron Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker RENE. The last closing price for Reneuron was 3.05p. Over the last year, Reneuron shares have traded in a share price range of 2.95p to 10.25p.

Reneuron currently has 57,173,760 shares in issue. The market capitalisation of Reneuron is £1.74 million. Reneuron has a price to earnings ratio (PE ratio) of -0.32.

Reneuron Share Discussion Threads

Showing 7301 to 7324 of 8900 messages
Chat Pages: Latest  296  295  294  293  292  291  290  289  288  287  286  285  Older
DateSubjectAuthorDiscuss
12/9/2019
13:40
Thanks ,outsizec.com. Thought -afterwards, doh - that that was probably your line of thinking. All fine for now.
dogwalker
12/9/2019
12:11
Hi Dogwalker,
In smaller stocks I tend to "round up" rather than follow 'exact' prices.
£1.875 / £1.90 - we're on the same page ;-)
When I say "a definite break below 190" I mean a close of 180 (or below), for more than 1 day (to rule out a downward 'spike' that immediately recovers), or a close of week price at that level.

outsizeclothes.com
11/9/2019
16:39
What date does the £1.90 'resistance level' relate from , outsizeclthes.com? I ask because I'm using £1.8725 from 28th June as the same thing i.e we're at it now.
dogwalker
11/9/2019
15:37
Conversely, if we can hold onto £1.90 (+) the upside resistance becomes 240, then 270, then 3.20
outsizeclothes.com
11/9/2019
15:33
A definite break under £1.90 here is very bad news chart-wise.
Having, at under 190, gone through a "triple-bottom", the first area of support isn't until the £1 'resistance level' of July last year, and below that serious support does not kick in until late March's 80p.
If it closes at under 190p end of week, £1 inside 2 months is the chart's downside target.

outsizeclothes.com
10/9/2019
21:21
Still tanking on high volume ffs
bigspuds
10/9/2019
10:23
Manjana on the stroke trial but the previous results were mediocre and only helped the share price to decline to 48p. On the other hand, the results from the RP trial were excellent. Announcing the update to the latest RP trials to a major US ophthalmology meeting suggests the trial must be going well. Why would you want to embarrass yourself in front of your peers? Exosomes as a delivery vehicle in for nothing. And

"We remain in discussions with other commercial third parties regarding potential collaboration and/or out-licensing deals across our programmes."

dickbush
10/9/2019
09:09
Schumacher in for stem cell treatment too:
philh75
10/9/2019
08:55
But the RENE science is just as exciting!
bonzo
10/9/2019
08:09
Not such good news for rene though, ie, not connected to rene product!
rayrac
10/9/2019
03:13
That is truly wonderful,Making the blind see again.
elmfield
10/9/2019
02:38
Great news for James O'Brien! Very happy to see that he has benefitted from science that only a few years ago would seem to be a dream. Hope his recovery improves and improves! Exciting for RENE to be involved in such science.
lauders
09/9/2019
09:28
Not expecting much from the agm..unless we also have a decent rns at about the same time.
rayrac
07/9/2019
12:13
AGM next week.
dickbush
06/9/2019
18:09
Not looking good..needs some results/news.
rayrac
04/9/2019
06:31
Interesting and great news for the children it will help!



Retinal dystrophy is not a single condition, but comprises a wide range of disorders such as Retinitis Pigmentosa. Most retinal dystrophies are genetic, caused by a mistake in a patient's genes.

Today’s announcement provides treatment to those with a specific faulty gene, RPE65, which blocks the messages that make proteins in the eye which are essential for normal vision.

It is estimated there are currently up to 100 patients, including children and adults, living with the retinal dystrophy who will be eligible for the new treatment.

Around 3 to 5 babies are expected to be born every year suffering with the condition. In order to undergo the treatment, patients will be tested for the faulty gene and if they test positive they will be eligible.

NHS England reached a deal with manufacturer Novartis to fund the drug, which costs £613,410 per patient at full price.

lauders
02/9/2019
09:20
And an even stranger start to the week...no feeds!
rayrac
30/8/2019
19:46
Oh well, a strange end to the week? Don’t ask me how to interpret it.
rayrac
29/8/2019
22:53
My guess is the same as yours, Rayrac. I've seen this many times but I still don't know what the signals indicate. Fingers crossed.
dickbush
29/8/2019
21:23
The shares finished at 245p on my SIPP account
volsung
29/8/2019
20:49
3 shares a signal of some sort?

Very strange, not to keen on tomorrow’s opening.

rayrac
29/8/2019
18:14
Someone has sausage fingers...
masingi
29/8/2019
16:57
Let's hope so; and for the better. Hope someone hasn't offloaded a shedload of shares into the rise in the share price today.
investordave
29/8/2019
16:51
Ignore the close. Tomorrow's trading will sort it out.
dickbush
Chat Pages: Latest  296  295  294  293  292  291  290  289  288  287  286  285  Older

Your Recent History

Delayed Upgrade Clock